D72.829 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
2021/2022 ICD-10-CM Index › 'L' Terms › Index Terms Starting With 'L' (Leukocytosis) Index Terms Starting With 'L' (Leukocytosis) Leukocytosis D72.829
Oct 01, 2021 · D72.829 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D72.829 became …
Oct 01, 2021 · Leukemoid reaction. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. D72.823 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for …
Oct 01, 2021 · D72.820 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D72.820 became …
Elevated white blood cell count. Approximate Synonyms. Leukocytosis. Leukocytosis (increase white blood cells in blood) Clinical Information. A transient increase in the number of leukocytes in a body fluid. Transient increase in the number of leukocytes in a body fluid.
Leukocytosis (increase white blood cells in blood) Clinical Information. A transient increase in the number of leukocytes in a body fluid. Transient increase in the number of leukocytes in a body fluid.
D72.829 also applies to the following: Inclusion term (s): Elevated leukocytes, unspecified. Leukocytosis, unspecified. The use of ICD-10 code D72.829 can also apply to: Leukocytosis.
D72.829 is a valid billable ICD-10 diagnosis code for Elevated white blood cell count, unspecified . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also: Elevated, elevation. leukocytes D72.829.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. The cause is unknown.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
Leukocytosis is white blood cells (the leukocyte count) above the normal range in the blood. It is frequently a sign of an inflammatory response, most commonly the result of infection, but may also occur following certain parasitic infections or bone tumors. It may also occur after strenuous exercise, convulsions such as epilepsy, emotional stress, ...
Leukocytosis is white blood cells (the leukocyte count) above the normal range in the blood. It is frequently a sign of an inflammatory response, most commonly the result of infection, but may also occur following certain parasitic infections or bone tumors.
D72.828 is a billable diagnosis code used to specify a medical diagnosis of other elevated white blood cell count. The code D72.828 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism ( D50–D89) Other disorders of blood and blood-forming organs ( D70-D77) Other disorders of white blood cells ( D72)